Locations:
SearchAdvertisement
The neuroactive steroid significantly reduces seizures related to CDKL5 deficiency disorder
Retrospective series characterizes post-COVID-19 POTS, outlines next research goals
Integrates genetic and clinical data to distinguish from GEFS+ and milder epilepsies
Surgery can be a game changer when medications fail to control seizures
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Assessing the role of circadian disruption, characterizing patterns of thalamic atrophy
Minority Stroke Program addresses racial disparities pinpointed in a recent study
Guidance for treatment, including the role of post-ICU recovery clinics
More evidence needed on pharmacologic therapy alone and combined with gait training
Comparative MRI study suggests unique pathophysiology in COVID-19 context
Risk of agitation, delusions, personality change and more is shaped by early presentation
Advertisement
Advertisement